KORU Medical jumps on FDA marketing clearance for syringe infusion pump

Koru Medical Systems

11/11/2021 12:21

** Shares of medtech co  KRMD.O  rise as much as 10.6% to
$3.12 before the bell 
    ** KRMD received clearance from the U.S. FDA to market its
FreedomEdge infusion pump to deliver prefilled syringes of
Hizentra  urn:newsml:reuters.com:*:nBw9gHWfPa 
    ** Hizentra is used to bring antibody levels to normal in
adults and children suffering from forms of immunodeficiency 
    ** KRMD also reported Q3 results late on Wednesday, posting
net loss of 2 cents per share vs profit of 1 cent a year ago
 urn:newsml:reuters.com:*:nBw16mXkMa 
    ** Up to Wednesday's close, stock down ~53% YTD 

 (Reporting by Bhanvi Satija in Bengaluru)
 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))